Related Experiment Video
Updated: Dec 31, 2025

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
Downregulation of miR-200a protects cardiomyocyte against apoptosis
Yansong Wang1, Yanan Jiang2, Xi Sun3
1Department of Pain Management, Qunli Branch, The First Affiliated Hospital of Harbin Medical University, Harbin 150070, PR China; Department of Pharmacology (State-Province Key Laboratories of Biomedicine- Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin 150081, PR China.
Insights
MicroRNA-200a (miR-200a) is upregulated in acute myocardial infarction (AMI) and promotes apoptosis. Inhibiting miR-200a protects against AMI by downregulating Fus expression and reducing cardiomyocyte apoptosis.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- MicroRNA Research
Background:
- Acute myocardial infarction (AMI) is a leading cause of death, with underlying molecular mechanisms requiring further elucidation.
- Key regulators in ischemic heart disease pathogenesis, including microRNAs, remain incompletely understood.
- This study investigates the role of miR-200a in AMI pathogenesis.
Purpose of the Study:
- To investigate the involvement and mechanism of miR-200a in acute myocardial infarction.
- To explore miR-200a's regulatory role in cardiomyocyte apoptosis and its potential as a therapeutic target.
Main Methods:
- Established an AMI mouse model via left coronary artery ligation and an in vitro model using H₂O₂-treated cardiomyocytes.
- Utilized miR-200a mimics and inhibitors (AMO-200a) for functional studies.
- Assessed infarct size, cell apoptosis (flow cytometry), and gene/protein expression (RT-PCR, immunofluorescence, Western blot).
Main Results:
- AMI models exhibited increased apoptosis and elevated miR-200a expression in both myocardial tissue and cardiomyocytes.
- Inhibition of miR-200a (AMO-200a) reduced apoptosis and modulated apoptosis-related protein expression.
- Bioinformatics and experimental data confirmed miR-200a targets Fus mRNA, with miR-200a negatively regulating Fus expression, which was downregulated in AMI models.
Conclusions:
- The miR-200a-dependent apoptosis signaling pathway is crucial in AMI pathogenesis.
- miR-200a and its regulation of Fus represent a potential therapeutic target for AMI.
- Targeting miR-200a offers a promising strategy for mitigating myocardial injury in AMI.
Background/Aims:
Acute myocardial infarction (AMI) is a major clinical manifestation of ischemic heart disease and represents a significant cause of morbidity and mortality. However, key regulators in the pathogenesis of ischemic heart disease remain controversial. The present study was designed to investigate the involvement of miR-200a and its related mechanism in AMI.
Methods:
Left coronary artery (LCA) ligation was conducted to induce an AMI mouse model. The infarct size was measured by TTC staining. H2O2 was used to induce an AMI model in vitro. miR-200a mimics, anti-miR-200a antisense oligodeoxyribonucleotides (AMO-200a), as well as corresponding negative controls were transfected into cardiomyocytes to observe the effect of miR-200a. Flow cytometry was used to detect cell apoptosis. Real-time PCR, immunofluorescence and western blot assays were used to evaluate gene expression at RNA or protein levels, respectively.
Results:
Apoptosis was activated in AMI models. The expression of miR-200a was upregulated both in the peri-infarcted region of mice myocardium and H2O2-treated cardiomyocytes. The co-administration of AMO-200a decreased the number of apoptosis cells and altered the expression of apoptosis related proteins. Interestingly, bioinformatics analysis results revealed that miR-200a could bind to the 3'-untranslated regions (3'-UTR) of Fus mRNA. In addition, the expression of Fus was downregulated in the AMI mouse models and in H2O2-treated cardiomyocytes. The alteration of miR-200a negatively regulated Fus expression in cardiomyocytes. Also, the protective effect of AMO-200a was observed through its regulation of Fus.
Conclusion:
MiR-200a-dependent apoptosis signaling pathway plays an important role in the pathogenesis of AMI injury and could be an exciting potential therapeutic target.
More Related Videos
09:16Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
09:41Visualization of Cell Cycle Variations and Determination of Nucleation in Postnatal Cardiomyocytes
Published on: February 24, 2017
Related Concept Videos
MicroRNAs
MicroRNAs
The Intrinsic Apoptotic Pathway